NCT06940947 2025-11-20
ETHOS
Norwegian Department of Health and Social Affairs
Phase 3 Recruiting
Clinical Trials
5 trialsNCT06617936 2025-07-15
Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Phase 2 Recruiting
NCT06363591 2025-03-05
WoW
Vastra Gotaland Region
Phase NA Recruiting
NCT06737822 2025-03-04
SurVIC
All India Institute of Medical Sciences, Jodhpur
Phase 3 Recruiting
NCT04890171 2024-12-27
ERASE-GC
National Cancer Center, Korea
Phase NA Recruiting